Currently out of the existing stock ratings of Joseph Thome, 12 are a BUY (54.55%), 10 are a HOLD (45.45%).

Joseph Thome

Work Performance Price Targets & Ratings Chart

Analyst Joseph Thome works at TD COWEN with a stock forecast success ratio of 35.71% fulfilled within 35.14 days on average. Previously, Joseph Thome worked at COWEN.

Joseph Thome’s has documented 45 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PTCT, PTC Therapeutics at 01-Mar-2024.

Wall Street Analyst Joseph Thome

Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/20/2020. The price target of $50 was fulfilled within 1 day with a profit of $3.29 (6.17%) receiving and performance score of 61.74.

Average potential price target upside

AXSM Axsome Therapeutics PTCT PTC Therapeutics UTHR United Therapeutics ESPR Esperion Therapeutics NTLA Intellia Therapeutics MRNS Marinus Pharmaceuticals TRDA Entrada Therapeutics EPZM Epizyme CERE Cerevel Therapeutics Holdings ALLK Allakos CMRX Chimerix

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

190

$117.89 (163.49%)

190

17 days ago

6/24 (25%)

$113.01 (146.79%)

108

Buy

109

$36.89 (51.16%)

108

22 days ago

8/14 (57.14%)

$29.2 (36.59%)

148

Buy

125

$52.89 (73.35%)

110

1 months 29 days ago

5/10 (50%)

$42.89 (52.23%)

82

Buy

108

$35.89 (49.77%)

108

1 months 30 days ago

7/15 (46.67%)

$26.86 (33.10%)

49

Buy

111

$38.89 (53.93%)

66

2 months 13 days ago

1/2 (50%)

$16.19 (17.08%)

157

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Joseph Thome is most bullish on?

Potential upside of $3.12 has been obtained for PTCT (PTC THERAPEUTICS)

Which stock is Joseph Thome is most reserved on?

Potential downside of $2.79 has been obtained for CERE (CEREVEL THERAPEUTICS HOLDINGS)

What Year was the first public recommendation made by Joseph Thome?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?